Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth

被引:115
|
作者
Takeda, K
Smyth, MJ
Cretney, E
Hayakawa, Y
Yamaguchi, N
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Peter MacCallum Canc Inst, Sir Donald & Lady Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia
[3] Toyama Med & Pharmaceut Univ, Res Inst Nat Med, Dept Pathogan Biochem, Toyama 9300194, Japan
[4] Juntendo Univ, Sch Med, Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan
基金
英国医学研究理事会;
关键词
TRAIL; NK cells; IFN-gamma; tumor growth;
D O I
10.1006/cimm.2001.1896
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NK) cells and interferon- (IFN) gamma have been implicated in immune surveillance against tumor development. Here we show tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which is a type II membrane protein belonging to the TNF family and plays a critical role in the NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous growth of TRAIL-sensitive tumors. Administration of a neutralizing monoclonal antibody against TRAIL promoted outgrowth of subcutaneously inoculated TRAIL-sensitive tumors (L929, LB27.4, and Renca) but not TRAIL-resistant tumors (P815 and 1316). Such a protective effect of TRAIL against TRAIL-sensitive tumors was abrogated in NK cell-depleted or IFN-gamma-deficient mice. These results suggested a substantial role of TRAIL as the effector molecule that eliminates subcutaneously developing TRAIL-sensitive tumors. (C) 2001 Elsevier Science (USA).
引用
收藏
页码:194 / 200
页数:7
相关论文
共 50 条
  • [1] The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis
    Michowitz, Y
    Goldstein, E
    Roth, A
    Afek, A
    Abashidze, A
    Ben Gal, Y
    Keren, G
    George, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) : 1018 - 1024
  • [2] Involvement of tumor necrosis factor-retated apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases
    Saitou, Y
    Shiraki, K
    Fuke, H
    Inoue, T
    Miyashita, K
    Yamanaka, Y
    Yamaguchi, Y
    Yamamoto, N
    Ito, K
    Sugimoto, K
    Nakano, T
    HUMAN PATHOLOGY, 2005, 36 (10) : 1066 - 1073
  • [3] Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand
    Ehtesham, M
    Kabos, P
    Gutierrez, MAR
    Chung, NHC
    Griffith, TS
    Black, KL
    Yu, JS
    CANCER RESEARCH, 2002, 62 (24) : 7170 - 7174
  • [4] Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Vascular Calcification
    Chasseraud, Maud
    Liabeuf, Sophie
    Mozar, Anais
    Mentaveri, Romuald
    Brazier, Michel
    Massy, Ziad A.
    Kamel, Said
    THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (02) : 140 - 146
  • [5] Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis
    Secchiero, Paola
    Zauli, Giorgio
    CURRENT OPINION IN HEMATOLOGY, 2008, 15 (01) : 42 - 48
  • [6] Tumor necrosis factor-related apoptosis-inducing ligand and cardiovascular disease
    Ebert, Thomas
    Fasshauer, Mathias
    ATHEROSCLEROSIS, 2011, 215 (02) : 279 - 280
  • [7] Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma
    Yang, XH
    Thiele, CJ
    CANCER LETTERS, 2003, 197 (1-2) : 137 - 143
  • [8] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling
    Thorburn, Andrew
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : 461 - 465
  • [9] Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation
    Xie, LX
    Shi, WY
    Guo, P
    TRANSPLANTATION, 2003, 76 (11) : 1556 - 1559
  • [10] IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand
    Du, Jingchun
    Zhou, Liwen
    Chen, Xiaoyong
    Yan, Sunxing
    Ke, Ming
    Lu, Xiaofang
    Wang, Zhen
    Yu, Weihua
    Xiang, Andy Peng
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2012, 44 (08): : 1305 - 1314